NM_020376.4(PNPLA2):c.421-9G>T AND Neutral lipid storage myopathy
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Dec 5, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003600587.2
Allele description [Variation Report for NM_020376.4(PNPLA2):c.421-9G>T]
NM_020376.4(PNPLA2):c.421-9G>T
Condition(s)
-
PREDICTED: Egretta garzetta lysophospholipase 2 (LYPLA2), transcript variant X2,...
PREDICTED: Egretta garzetta lysophospholipase 2 (LYPLA2), transcript variant X2, mRNAgi|1894682412|ref|XM_035903983.1|Nucleotide
-
LOW QUALITY PROTEIN: exostosin-1-like [Leucoraja erinaceus]
LOW QUALITY PROTEIN: exostosin-1-like [Leucoraja erinaceus]gi|2497494795|ref|XP_055491462.1|Protein
-
dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase [Egretta garzetta...
dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase [Egretta garzetta]gi|697824326|ref|XP_009632622.1|Protein
-
CD109 antigen isoform X3 [Ursus americanus]
CD109 antigen isoform X3 [Ursus americanus]gi|2176620558|ref|XP_045659733.1|Protein
-
PREDICTED: Mus musculus transient receptor potential cation channel, subfamily M...
PREDICTED: Mus musculus transient receptor potential cation channel, subfamily M, member 7 (Trpm7), transcript variant X4, mRNAgi|1907142478|ref|XM_036162436.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024